Abstract: Embodiments disclose herein implement a computing system in a computing network with hardware and software components of clinical system resources. The computing network may be a closed, private network. The clinical system resources may be situated on-premises or otherwise geographically proximate to the clinical installation (e.g., hospital, healthcare clinic). The clinical system resources may be heterogenous resources. The clinical system resources may access or execute interface programs (e.g., APIs) for performing interoperability operations on input data or instructions from the clinic database or upstream clinical system resource of the clinical networked computing system. For instance, the interface program may, for example, translate the data format of instructions or application data, or authenticate an upstream clinical system resource that sent the application data or instructions, among others.

Abstract: A compound having the following structure of Formula (IV): or a stereoisomer, salt, or tautomer thereof, wherein R1, R2, R3, A, B, X, and Y are as defined herein. Pharmaceutical composition comprising the compounds, and their use in methods of treating diseases are also described.

Abstract: Systems, methods, apparatuses, and devices, for the wireless communication of analyte data are provided. In some embodiments, a method and calibration station for calibrating a continuous analyte sensor system is provided. Methods and testing systems for testing a continuous analyte sensor system is provided. Continuous analyte sensor systems, display devices and peripheral devices configured for wireless communication of analyte, connection, alarm and/or alert data and associated methods are provided.

Abstract: Examples of the present disclosure describe systems and methods for providing enhanced security in edge computing environments. A first aspect describes a method for moving security features dynamically applied to an application at a first deployment location to an application at a second deployment location. A second aspect describes a method for locally expanding/contracting an instance of a deployed application. A third aspect describes a method for redirected network traffic associated with detected malicious conduct from a first application deployment environment to a secured second application deployment environment. A fourth aspect describes a method for performing multi-stage network traffic filtering.

Abstract: Methods, devices and systems are disclosed for inter-app communications between software applications on a mobile communications device. In one aspect, a computer-readable medium on a mobile computing device comprising an inter-application communication data structure to facilitate transitioning and distributing data between software applications in a shared app group for an operating system of the mobile computing device includes a scheme field of the data structure providing a scheme id associated with a target software app to transition to from a source software app, wherein the scheme id is listed on a scheme list stored with the source software app; and a payload field of the data structure providing data and/or an identification where to access data in a shared file system accessible to the software applications in the shared app group, wherein the payload field is encrypted.

Abstract: The present relates to vision based automated syringe volume measurement. This can include a method and system for syringe volume measurement. The method can include filling a volume of liquid into a syringe, which volume of liquid is unknown, positioning the syringe for imaging with a high-resolution camera, capturing an image of the syringe with the high-resolution camera, and evaluating the image of the syringe to determine the volume of liquid in the syringe.

Abstract: Systems and methods for controlling a display system. The methods comprise: detecting an occurrence of an event; initiating a display session based on the event being of an event type to trigger a display session; and selecting media content (MC) for display by computing devices (ICDs) (wherein ICDs are located in areas or sections (SA/S) of a venue); selecting a first SA/S at which display of MC is to begin; identifying first CDs (FCDs) that are located in the first SA/S; causing FCDs to notify users that FCDs are to be moved into positions in which first pixel panels are visible by persons located outside of the first SA/S; and causing each FCD to display a respective pixel portion of a first electronic graphic (FEI) contained in MC, whereby an entirety of FEI is displayed collectively by FCDs.

Abstract: Embodiments of the present disclosure include methods and compositions for functionalizing molecules, such as oligonucleotides, with functional groups, including polyhistidine tags useful in affinity methods. Some embodiments include methods for modifying and purifying complex mixtures of molecules by exchange of functional tags.

Abstract: Surgical anchors and related systems and methods that utilize sutures or other flexible, elongated members to actively deploy a deformable anchor body in a manner that facilitates better deployment of the anchor in the bone, resulting in better fixation and resistance to pull out.

Abstract: Various implementations include systems and approaches for grouping speakers. In some cases, a method includes, configuring a first set of acoustic properties to be applied to an audio device in response to detecting an identifier for a given location; in response to detecting the identifier, automatically applying the first set of acoustic properties to the audio device for audio playback; and in response to no longer detecting the identifier, automatically applying a second set of acoustic properties to the audio device for audio playback, the second set of acoustic properties being different from the first set of acoustic properties in at least one aspect.

Abstract: Described herein are compounds of Formula I: I and their pharmaceutically acceptable salts, wherein R1, R2, R3, R4, R7, RF, t1, Y1, and Y2 are defined herein; their use as MC4R antagonists; pharmaceutical compositions containing such compounds and salts; the use of such compounds and salts to treat, for example, cachexia, anorexia, or anorexia nervosa; and intermediates and processes for preparing such compounds and salts.

Abstract: Disclosed herein are computer-implemented method, system, and computer-readable storage-medium embodiments for implementing template-based excerpting and rendering of multimedia performances technologies. An embodiment includes at least one computer processor configured to retrieve a first content instance and applying a template that results in transforming the first content instance. The first content instance may include a plurality of structural elements. The first content instance may be transformed by a rendering engine running on the at least one computer processor and/or transmitted to a content-playback device. An embodiment of transforming the first content instance includes trimming the content instance based on requirements provided by social media platforms.

Abstract: Systems and methods for remote and host monitoring communication are disclosed. In some implementations, monitoring systems can comprise a host monitoring device associated with a Host communicatively coupled to one or more remote monitoring devices associated with Remote Monitors. The host monitoring device can send communications based at least in part on analyte measurements of a Host sensor and/or other contextual data giving such measurements context. Different remote monitoring devices can receive different communications based at least in part on the role of the respective Remote Monitors relative to the Host. These roles can be reflected in classifications of Remote Monitors.

Abstract: A dosing unit for use in an automatic dosing system of a water-bearing household appliance, for automatically dosing a dosing amount of a solid detergent, the dosing unit comprising a dosing cartridge for storing a bulk of the solid detergent and a dosing device for separating the dosing amount from the bulk and releasing the separated dosing amount by linearly displacing a sliding element from a separating position to a release position, wherein the dosing device includes a dosing channel, wherein, when the sliding element is in the separating position, the dosing channel is configured for receiving at least the dosing amount from the bulk and intermediately storing the dosing amount in a pre-dosing position, and, when the sliding element is in the release position, the dosing device is configured for releasing the dosing amount intermediately stored in the pre-dosing position.

Abstract: Systems, devices, and methods including a processor having addressable memory, where the processor is configured to: collect, via a set of sensors, biological signals related to patient status; collect, via an environmental monitoring device, environmental data associated with an environment of the patient; store, locally via a secure encrypted local database, the collected biological signals and the collected environmental data; detect an abnormality in the collected biological signals; increase measurement frequency of the biological signals by the set of sensors based on the detected abnormality; detect an error in the collected biological signals; determine whether the detected error in the collected biological signals of the current reading is due to environmental factors; correct the determined error in the collected biological signals; and transmit the error corrected collected biological signals as encrypted data.

Abstract: A continuous glucose monitor for wirelessly transmitting data relating to glucose value to a plurality of displays is disclosed, as well as systems and methods for limiting the number of display devices that can connect to a continuous glucose transmitter. In addition, security, including hashing techniques and a changing application key, can be used to provide secure communications between the continuous glucose transmitter and the displays. Also provided is a continuous glucose monitor and techniques for authenticating multiple displays, providing secure data transmissions to multiple displays, and coordinating the interaction of commands and data updates between multiple displays.

Abstract: Described herein is a crystalline form of (2R)-2-(5-fluoro-2-methoxypyridin-4-yl)-1-[(2S)-7-methyl-6-(pyrimidin-2-yl)-3,4-dihydro-1H-spiro[1,8-naphthyridine-2,3-pyrrolidin]-1-yl]propan-1-one having a powder X-ray diffraction pattern comprising at least one characteristic peak, in terms of 2? at a copper wavelength, selected from 8.7±0.2, 11.1±0.2, and 13.3±0.2.

Abstract: A computer system includes a physical memory having a first page table and a second page table, and an address translation module. The first page table includes primary page table entries, where each page table entry among the primary page table entries is configured to store a mapping of a virtual memory address to a physical memory address and auxiliary information. The second page table includes secondary page table entries each storing at least one further auxiliary information, where each secondary page table entry corresponds to a primary page table entry in the first page table. The address translation module is configured to, in response to receiving a request from a processor, walk through the first page table to identify a primary page table entry and consecutively identify a location of a corresponding secondary page table entry based on a location of the primary page table entry.

Abstract: A compound having the following structure of Formula (IV): or a stereoisomer, salt, or tautomer thereof, wherein R1, R2, R3, A, B, X, and Y are as defined herein. Pharmaceutical composition comprising the compounds, and their use in methods of treating diseases are also described.